ESR1 and breast cancer: Luminal breast cancer that expresses ERα represents approximately 70% and includes the subtypes luminal A (ERα+, PR+, HER2−, and low Ki-67) and luminal B (ERα+, PR+/−, HER2−/+, and high Ki-67) (2, 3).